Ashok Leyland shares surge 6% after posting 20% YoY increase in Q4 profit. Should you invest?

Ashok Leyland shares surged nearly 6% on BSE to a record high after reporting a 20% YoY increase in its Q4 net profit.

shares zoomed nearly 6% on BSE today to their new all-time high of Rs 222.80 after reporting a 20% year-on-year (YoY) in its Q4 net at Rs 900.41 crore.

from in the quarter under review stood at Rs 11,266.69 crore as compared to Rs 11,625.67 crore in the year-ago period.

Here’s how view the Q4 :



Demand momentum in the domestic market continues to remain healthy led by pick-up in replacement demand. The company reiterated its focus on profitable growth. Medium-term demand drivers (higher infra spends, scrappage policy, etc.) remain intact and AL aims for higher share in MHCVs (to c.35%) and LCV led by network expansion and addressing product gaps.

maintained a 'buy' rating on stock with a target price of Rs 275.



Motilal expects a recovery in CV demand from 2HFY25 onwards as structural demand drivers remain intact. The company is the best choice in the CV growth cycle, as it has positioned itself to expand revenue/profit pools. Moreover, its focus on profitable growth driven by lower discounts, a better mix, and cost control measures should bode well for EBITDA margin expansion over FY24-26E.

The brokerage firm raised its FY25E/FY26E EPS by 7%/6% to factor in a better gross margin and a lower interest burden.

They have a 'buy' call on the stock with a target price of Rs 245.

Also read:




KIE expects CV industry volumes to recover post elections, especially driven by the buses segment. Also, they expect profitability of the company to be maintained at current levels in FY2025E driven by increase in non-auto mix and cost-control measures.

Kotak has a 'reduce' rating on the stock with a target price of Rs 200.



ICICI Securities is expecting overall switch mobility to remain EBITDA positive in FY25 aided by India business' strong pipeline. ICICI Securities has built in flat volumes for the domestic M&HCV goods industry in FY25E, before a 10% dip in FY26E, thus factoring in AL’s M&HCV volume CAGR at 6% over FY24-26E, assuming steady market share.

ICICI Securities has a 'sell' view on the stock with a target price of Rs 140.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Source: Stocks-Markets-Economic Times

Последние публикации
Investors "discounting" Google's possible loss of Apple search deal - Oppenheimer
25.09.2024 - 18:00
Apple stock: New Street Research sees a 10% miss on iPhone 16 shipments
25.09.2024 - 18:00
Cintas earnings beat by $0.10, revenue topped estimates
25.09.2024 - 18:00
Explainer-California says Exxon's recycling claims created a 'public nuisance.' What does that mean?
25.09.2024 - 18:00
BBVA CEO remains bullish on Mexico ahead of presidential transition
25.09.2024 - 18:00
Merrill Lynch, Harvest Volatility Management to pay $9.3 million to settle SEC charges
25.09.2024 - 18:00
Southwest plans to reduce service and staffing in Atlanta, union says
25.09.2024 - 18:00
NVIDIA, Flutter and HPE lead morning market cap stock movers on Wednesday
25.09.2024 - 18:00
FTC announces crackdown on deceptive AI claims and schemes
25.09.2024 - 18:00
Southwest plans to reduce Atlanta service, cut some jobs, union says
25.09.2024 - 17:00
Germany turns up heat on UniCredit as Orcel urges talks over Commerzbank
25.09.2024 - 17:00
Google: Signs that enterprise adoption of AI Is inflecting, says JMP Securities
25.09.2024 - 16:00
UniCredit overtures hold few fears for Germany's Mittelstand
25.09.2024 - 16:00
Hewlett Packard Enterprise upgraded to "Overweight" by Barclays
25.09.2024 - 16:00
Obesity drug developer BioAge Labs aims up to $640 million valuation in upsized US IPO
25.09.2024 - 16:00

© Analytic DC. All Rights Reserved.

new
Обзор рынка ЗАПАСЫ СЫРОЙ НЕФТИ В США -4,471М
Добро пожаловать в чат поддержки!
*
*

Ваш запрос успешно отправлен!
Скоро с вами свяжутся.